Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Third-generation zotarolimus-eluting and everolimus-eluting stents in all-comer patients requiring a percutaneous coronary intervention (DUTCH PEERS): a randomised, single-blind, multicentre, non-inferiority trial.
von Birgelen C, Sen H, Lam MK, Danse PW, Jessurun GA, Hautvast RW, van Houwelingen GK, Schramm AR, Gin RM, Louwerenburg JW, de Man FH, Stoel MG, Löwik MM, Linssen GC, Saïd SA, Nienhuis MB, Verhorst PM, Basalus MW, Doggen CJ, Tandjung K. von Birgelen C, et al. Among authors: verhorst pm. Lancet. 2014 Feb 1;383(9915):413-23. doi: 10.1016/S0140-6736(13)62037-1. Epub 2013 Oct 31. Lancet. 2014. PMID: 24183564 Clinical Trial.
A randomized controlled trial in second-generation zotarolimus-eluting Resolute stents versus everolimus-eluting Xience V stents in real-world patients: the TWENTE trial.
von Birgelen C, Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, Louwerenburg JH, Linssen GC, Saïd SA, Kleijne MA, Sen H, Löwik MM, van der Palen J, Verhorst PM, de Man FH. von Birgelen C, et al. Among authors: verhorst pm. J Am Coll Cardiol. 2012 Apr 10;59(15):1350-61. doi: 10.1016/j.jacc.2012.01.008. Epub 2012 Feb 15. J Am Coll Cardiol. 2012. PMID: 22341737 Free article. Clinical Trial.
Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and Xience V drug-eluting stents.
Sen H, Tandjung K, Basalus MW, Löwik MM, van Houwelingen GK, Stoel MG, Louwerenburg HW, de Man FH, Linssen GC, Nijhuis R, Nienhuis MB, Verhorst PM, van der Palen J, von Birgelen C. Sen H, et al. Among authors: verhorst pm. EuroIntervention. 2012 Oct;8(6):664-71. doi: 10.4244/EIJV8I6A104. EuroIntervention. 2012. PMID: 22581199 Free article. Clinical Trial.
Clinical outcome following stringent discontinuation of dual antiplatelet therapy after 12 months in real-world patients treated with second-generation zotarolimus-eluting resolute and everolimus-eluting Xience V stents: 2-year follow-up of the randomized TWENTE trial.
Tandjung K, Sen H, Lam MK, Basalus MWZ, Louwerenburg JHW, Stoel MG, van Houwelingen KG, de Man FHAF, Linssen GCM, Saïd SAM, Nienhuis MB, Löwik MM, Verhorst PMJ, van der Palen J, von Birgelen C. Tandjung K, et al. Among authors: verhorst pmj. J Am Coll Cardiol. 2013 Jun 18;61(24):2406-2416. doi: 10.1016/j.jacc.2013.04.005. Epub 2013 Apr 16. J Am Coll Cardiol. 2013. PMID: 23602769 Free article. Clinical Trial.
Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial.
Sen H, Lam MK, Tandjung K, Basalus MW, de Man FH, Louwerenburg JH, Stoel MG, van Houwelingen GK, Löwik MM, Linssen GC, Saïd SA, Nienhuis MB, Verhorst PM, van der Palen J, von Birgelen C. Sen H, et al. Among authors: verhorst pm. EuroIntervention. 2014 Oct;10(6):664-71. doi: 10.4244/EIJV10I6A117. EuroIntervention. 2014. PMID: 25330500 Free article. Clinical Trial.
TWENTE Study: The Real-World Endeavor Resolute Versus Xience V Drug-Eluting Stent Study in Twente: study design, rationale and objectives.
Basalus MW, Tandjung K, van Houwelingen KG, Stoel MG, de Man FH, Louwerenburg JW, Saïd SA, Linssen GC, Kleijne MA, van der Palen J, Huisman J, Verhorst PM, von Birgelen C. Basalus MW, et al. Among authors: verhorst pm. Neth Heart J. 2010 Aug;18(7-8):360-4. doi: 10.1007/BF03091792. Neth Heart J. 2010. PMID: 20730003 Free PMC article.
Dedicated calibration formulas permit correction of differences between measurements by different IVUS devices as demonstrated in atherosclerotic human coronary arteries in vitro.
Hartmann M, von Birgelen C, Mintz GS, Deppermann N, Dirsch O, Stoel MG, van Houwelingen GK, Louwerenburg HW, Verhorst PM, Erbel R. Hartmann M, et al. Among authors: verhorst pm. Int J Cardiovasc Imaging. 2006 Oct;22(5):605-13. doi: 10.1007/s10554-006-9092-9. Epub 2006 Apr 29. Int J Cardiovasc Imaging. 2006. PMID: 16649074
Staged therapeutic approach in spontaneous coronary dissection.
Aliyary S, Mariani MA, Verhorst PM, Hartmann M, Stoel MG, von Birgelen C. Aliyary S, et al. Among authors: verhorst pm. Ann Thorac Surg. 2007 May;83(5):1879-81. doi: 10.1016/j.athoracsur.2006.11.085. Ann Thorac Surg. 2007. PMID: 17462423
Impact of analyzing less image frames per segment for radiofrequency-based volumetric intravascular ultrasound measurements in mild-to-moderate coronary atherosclerosis.
Huisman J, Hartmann M, Mattern ES, Mintz GS, Basalus MW, van Houwelingen GK, Verhorst PM, von Birgelen C. Huisman J, et al. Among authors: verhorst pm. Int J Cardiovasc Imaging. 2010 Jun;26(5):487-97. doi: 10.1007/s10554-010-9599-y. Epub 2010 Feb 27. Int J Cardiovasc Imaging. 2010. PMID: 20191323 Free PMC article.
50 results